Increased visceral adipose tissue and altered adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors

Abstract

Objective

Visceral adipose tissue (VAT) correlates with cardiovascular risk factors and has never been assessed in systemic lupus erythematosus (SLE). Our aim was to evaluate VAT in premenopausal SLE patients.

Methods

Sixty-three premenopausal SLE patients and 186 age-matched healthy women were included. Demographic, anthropometric, disease and treatment parameters were evaluated. VAT was measured by dual X-ray absorptiometry (DXA) with APEX 4.0 software.

Results

SLE patients had a disease duration of 5.25 ± 3.80 years, SLEDAI activity score of 4.35 ± 5.13, SLICC/ACR-DI of 0.70 ± 0.80, current prednisone dose of 11.60 ± 12.10 mg/day and cumulative glucocorticoid dose of 22.34 ± 12.94 g. Overweight/obese SLE patients and controls had similar VAT parameters (p > 0.05). Among individuals with BMI <25 kg/m², SLE patients and controls had similar weight, fat mass and fat percentage (p > 0.05) but patients had higher values of VAT parameters (VAT mass: 260.60 ± 117.23 vs. 194.77 ± 71.42 g, p = 0.001; VAT area: 54.05 ± 24.30 vs. 40.40 ± 14.82 cm², p = 0.001; VAT volume: 281.75 ± 126.81 vs. 210.61 ± 77.29 cm³, p = 0.001) and trunk/limb fat mass ratio (0.78 ± 0.21 vs. 0.67 ± 0.12, p = 0.002) compared to controls. In SLE, VAT area correlated with weight (r = 0.66, p < 0.001), non-HDL cholesterol (r = 0.53, p < 0.001), LDL cholesterol (r = 0.48, p < 0.001) and triglycerides (r = 0.33, p = 0.008), but not with disease duration, SLEDAI, SLICC/ACR-DI or current glucocorticoid use (p > 0.05).

Conclusion

This study provides original evidence that SLE is associated with increased VAT and altered adiposity distribution. The correlation with traditional risk factors for cardiovascular disease, independent of current glucocorticoid dose and disease activity, suggests the role of visceral fat as an additional tool for risk assessment in these young patients.

Keywords

Systemic lupus erythematosus visceral adipose tissue cardiovascular risk factors

Get full access to this article

View all access options for this article.

References

Symmons

Gabriel

. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7: 399–408.

Schoenfeld

Kasturi

Costenbader

. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review. Semin Arthritis Rheum 2013; 43: 77–95.

Fox

Massaro

Hoffmann

et al.

Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39–48.

Micklesfield

Goedecke

Punyanitya

Wilson

Kelly

. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity (Silver Spring) 2012; 20: 1109–1114.

Kaul

Rothney

Peters

et al.

Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) 2012; 20: 1313–1318. Erratum in: Obesity (Silver Spring) 2012; 20: 1544.

Tan

Cohen

Fries

et al.

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.

Bombardier

Gladman

Urowitz

et al.

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640.

Gladman

Ginzler

Goldsmith

et al.

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

Miazgowski

Krzyżanowska-Świniarska

Dziwura-Ogonowska

Widecka

. The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women. Endocrine 2014; 47: 500–505.

10.

Bazzocchi

Ponti

Cariani

et al.

Visceral fat and body composition changes in a female population after RYGBP: A two-year follow-up by DXA. Obes Surg 2015; 25: 443–451.

11.

Lewiecki

Gordon

Baim

et al.

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 2008; 43: 1115–1121.

12.

Evans

. Straightforward statistics for the behavioral sciences, Pacific Grove, CA: Brooks/Cole Publishing, 1996.

13.

Bredella

Gill

Keating

et al.

Assessment of abdominal fat compartments using DXA in premenopausal women from anorexia nervosa to morbid obesity. Obesity (Silver Spring) 2013; 21: 2458–2464.

14.

Shields

Barinas-Mitchell

Gingo

et al.

Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. Atherosclerosis 2013; 231: 129–135.

15.

Wajchenberg

. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697–738.

16.

Saijo

Kiyota

Kawasaki

et al.

Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249–258.

17.

Alexopoulos

Katritsis

Raggi

. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 2014; 233: 104–112.